![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
Cipla receives final USFDA approval for generic version of Shire’s Firazyr
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States...
Press Releases
Merck Opens its Largest M Lab Collaboration Center in Shanghai
Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
“With the booming...
News
Gilead presents additional data on investigational antiviral remdesivir to treat COVID-19 at Virtual COVID-19 Conference
Gilead Sciences Inc, announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on...
News
Glenmark reduces price of oral antiviral FabiFlu by 27% in India
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a post marketing surveillance (PMS) study on FabiFlu to closely...
Drug Research
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies...
Press Releases
ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution
Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into a collaboration with STERIS, a leading provider of infection...
Drug Research
Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API
Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read